(1 - 7 von 9
)
Basilea Pharmaceutica AG: Basilea announces licensing of a novel ...www.finanznachrichten.de › nachrichten
www.finanznachrichten.de
— Dr. Laurenz Kellenberger, Chief Scientific Officer of Basilea, said: "This agreement shows our commitment to implementing our new corporate ...
Basilea Pharma: FDA Allows To Proceed With Phase Daily Adventwww.dailyadvent.com › news
www.dailyadvent.com
Laurenz Kellenberger, Chief Scientific Officer of Basilea, said: "The drug candidate offers the potential for a targeted development strategy in multiple ...
Swiss Life Sciences Database - Biotechgatewww.biotechgate.com › swiss › portal › news_details
www.biotechgate.com
Dr. Laurenz Kellenberger, Chief Scientific Officer of Basilea, said: “We are very pleased with the strong single agent anti-cancer activity observed in ...
Basilea reports preclinical data on oncology drug candidates BAL0891www.pharmatutor.org › pharma-news › basilea-repo...
www.pharmatutor.org
— Dr. Laurenz Kellenberger, Chief Scientific Officer of Basilea, said: “The data presented at the AACR Annual Meeting confirm the ...
sortiert nach Relevanz / Datum